 | • レポートコード：MRC2103G111 • 出版社/出版日：Transparency Market Research / 2020年11月2日 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprisewide Licence | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査資料では、世界の合成カンナビノイド市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場展望、製品タイプ別（高純度合成カンナビノイド、超高純度合成カンナビノイド）分析、疾患別分析、流通チャネル別分析、地域別（北米、ヨーロッパ、中南米、その他）分析、競争状況など、以下の構成でまとめております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場展望 ・合成カンナビノイドの世界市場規模：製品タイプ別（高純度合成カンナビノイド、超高純度合成カンナビノイド） ・合成カンナビノイドの世界市場規模：疾患別 ・合成カンナビノイドの世界市場規模：流通チャネル別 ・合成カンナビノイドの世界市場規模：地域別（北米、ヨーロッパ、中南米、その他） ・競争状況 |
Synthetic Cannabinoids Market – Scope of the Report
TMR’s report on the global synthetic cannabinoids market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global synthetic cannabinoids market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global synthetic cannabinoids market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global synthetic cannabinoids market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global synthetic cannabinoids market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global synthetic cannabinoids market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global synthetic cannabinoids market. The next section of the global synthetic cannabinoids market report highlights the USPs, which include epidemiology analysis, regulatory scenario, key industry events, technological advancements, and key success factors of top players operating in the global synthetic cannabinoids market.
The report also delves into the competition landscape of the global synthetic cannabinoids market. Key players operating in the global synthetic cannabinoids market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global synthetic cannabinoids market profiled in this report.
Key Questions Answered in Synthetic Cannabinoids Market Report
What are the major drivers, restraints, opportunities in the market?
What are the revenue share projections of key segments of the global synthetic cannabinoids market during the forecast period?
Which segment is likely to lead the global synthetic cannabinoids market in terms of revenue by 2030?
How mergers & acquisitions among players are widening the scope for the global synthetic cannabinoids market?
What is the market position of different companies operating in the global synthetic cannabinoids market?
Synthetic Cannabinoids Market – Research Objectives and Research Approach
The comprehensive report on the global synthetic cannabinoids market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind the study and healthcare compliances laid down by accredited agencies in the purview of research in the global synthetic cannabinoids market. It is followed by market introduction, market dynamics, and an overview of the global synthetic cannabinoids market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the global synthetic cannabinoids market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global synthetic cannabinoids market. The next section of the global synthetic cannabinoids market report highlights the USPs, which include regulatory scenario, epidemiology analysis, technological advancements, and key success factors of top players in the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global synthetic cannabinoids market in terms of product type, indication, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the synthetic cannabinoids market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Synthetic Cannabinoids Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.4. Global Synthetic Cannabinoids Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Export-Import Scenario
5.2. Global Regulatory Status of Synthetic Cannabinoids
5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
5.4. Current and Future Areas of Demand
5.5. Value Chain, Stakeholder
5.6. Pricing Analysis
5.7. Methods of Manufacturing Synthetic Cannabinoids
6. Global Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Product Type
6.1. Introduction & Definition
6.2. Global Synthetic Cannabinoids Market Value Forecast, by Product Type, 2018–2030
6.2.1. High-pure Synthetic Cannabinoids
6.2.2. Ultra-pure Synthetic Cannabinoids
6.3. Global Synthetic Cannabinoids Market Attractiveness Analysis, by Product Type
7. Global Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Indication
7.1. Introduction & Definition
7.2. Global Synthetic Cannabinoids Market Value Forecast, by Indication, 2018–2030
7.2.1. Pain Management
7.2.2. Nausea/Vomiting
7.2.3. Neurological Disorder Management
7.2.4. Others
7.3. Global Synthetic Cannabinoids Market Attractiveness Analysis, by Indication
8. Global Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Distribution Channel
8.1. Introduction
8.2. Global Synthetic Cannabinoids Market Value Forecast, by Distribution Channel, 2018–2030
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Online Pharmacies
8.3. Global Synthetic Cannabinoids Market Attractiveness Analysis, by Distribution Channel
9. Global Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Region
9.1. Introduction
9.2. Synthetic Cannabinoids Market Value Forecast, by Region, 2018–2030
9.2.1. North America
9.2.2. Europe
9.2.3. Latin America
9.2.4. Rest of the World
9.3. Global Synthetic Cannabinoids Market Attractiveness Analysis, by Region
10. North America Synthetic Cannabinoids Market Analysis and Forecast
10.1. Introduction
10.2. North America Synthetic Cannabinoids Market Value Forecast, by Product Type, 2018–2030
10.2.1. High-pure Synthetic Cannabinoids
10.2.2. Ultra-pure Synthetic Cannabinoids
10.3. North America Synthetic Cannabinoids Market Value Forecast, by Indication, 2018–2030
10.3.1. Pain Management
10.3.2. Nausea/Vomiting
10.3.3. Neurological Disorder Management
10.3.4. Others
10.4. North America Synthetic Cannabinoids Market Value Forecast, by Distribution Channel, 2018–2030
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. North America Synthetic Cannabinoids Market Value Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. North America Synthetic Cannabinoids Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Indication
10.6.3. By Distribution Channel
10.6.4. By Country/Sub-region
11. Europe Synthetic Cannabinoids Market Analysis and Forecast
11.1. Introduction
11.2. Europe Synthetic Cannabinoids Market Value Forecast, by Product Type, 2018–2030
11.2.1. High-pure Synthetic Cannabinoids
11.2.2. Ultra-pure Synthetic Cannabinoids
11.3. Europe Synthetic Cannabinoids Market Value Forecast, by Indication, 2018–2030
11.3.1. Pain Management
11.3.2. Nausea/Vomiting
11.3.3. Neurological Disorder Management
11.3.4. Others
11.4. Europe Synthetic Cannabinoids Market Value Forecast, by Distribution Channel, 2018–2030
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Europe Synthetic Cannabinoids Market Value Forecast, by Country/Sub-region, 2018–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Synthetic Cannabinoids Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Indication
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Latin America Synthetic Cannabinoids Market Analysis and Forecast
12.1. Introduction
12.2. Latin America Synthetic Cannabinoids Market Value Forecast, by Product Type, 2018–2030
12.2.1. High-pure Synthetic Cannabinoids
12.2.2. Ultra-pure Synthetic Cannabinoids
12.3. Latin America Synthetic Cannabinoids Market Value Forecast, by Indication, 2018–2030
12.3.1. Pain Management
12.3.2. Nausea/Vomiting
12.3.3. Neurological Disorder Management
12.3.4. Others
12.4. Latin America Synthetic Cannabinoids Market Value Forecast, by Distribution Channel, 2018–2030
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Latin America Synthetic Cannabinoids Market Value Forecast, by Country/Sub-region, 2018–2030
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Latin America Synthetic Cannabinoids Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Indication
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Rest of the World Synthetic Cannabinoids Market Analysis and Forecast
13.1. Introduction
13.2. Rest of the World Synthetic Cannabinoids Market Value Forecast, by Product Type, 2018–2030
13.2.1. High-pure Synthetic Cannabinoids
13.2.2. Ultra-pure Synthetic Cannabinoids
13.3. Rest of the World Synthetic Cannabinoids Market Value Forecast, by Indication, 2018–2030
13.3.1. Pain Management
13.3.2. Nausea/Vomiting
13.3.3. Neurological Disorder Management
13.3.4. Others
13.4. Rest of the World Synthetic Cannabinoids Market Value Forecast, by Distribution Channel, 2018–2030
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Rest of the World Synthetic Cannabinoids Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By Indication
13.5.3. By Distribution Channel
14. Competition Landscape
14.1. Global Synthetic Cannabinoids Market Share Analysis, by Company, 2019
14.2. Company Profiles
14.2.1. Mylan N.V.
14.2.1.1. Company Description
14.2.1.2. Business Overview
14.2.1.3. Financial Overview
14.2.1.4. Strategic Overview
14.2.1.5. SWOT Analysis
14.2.2. Alkem Labs
14.2.2.1. Company Description
14.2.2.2. Business Overview
14.2.2.3. Financial Overview
14.2.2.4. Strategic Overview
14.2.2.5. SWOT Analysis
14.2.3. Noramco
14.2.3.1. Company Description
14.2.3.2. Business Overview
14.2.3.3. Financial Overview
14.2.3.4. Strategic Overview
14.2.3.5. SWOT Analysis
14.2.4. Lygos Inc.
14.2.4.1. Company Description
14.2.4.2. Business Overview
14.2.4.3. Financial Overview
14.2.4.4. Strategic Overview
14.2.4.5. SWOT Analysis
14.2.5. Hyasynth Biologicals, Inc.
14.2.5.1. Company Description
14.2.5.2. Business Overview
14.2.5.3. Financial Overview
14.2.5.4. Strategic Overview
14.2.5.5. SWOT Analysis
14.2.6. Renew Biopharma
14.2.6.1. Company Description
14.2.6.2. Business Overview
14.2.6.3. Financial Overview
14.2.6.4. Strategic Overview
14.2.6.5. SWOT Analysis
14.2.7. CannBioRx Life Sciences
14.2.7.1. Company Description
14.2.7.2. Business Overview
14.2.7.3. Financial Overview
14.2.7.4. Strategic Overview
14.2.7.5. SWOT Analysis
14.2.8. Ginkgo Bioworks
14.2.8.1. Company Description
14.2.8.2. Business Overview
14.2.8.3. Financial Overview
14.2.8.4. Strategic Overview
14.2.8.5. SWOT Analysis
Table 01: Synthetic Cannabinoids Market Price ($), Region, 2019
Table 02 : Global Synthetic Cannabinoids Market, by Product Type
Table 03: Global Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 04: Global Synthetic Cannabinoids Market, by Indication
Table 05: Global Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 06: Global Synthetic Cannabinoids Market, by Distribution Channel
Table 07: Global Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 08: Global Synthetic Cannabinoids Market, by Region
Table 09: Global Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 10: Global Synthetic Cannabinoids Market Prescription (Units) Forecast, by Region, 2018–2030
Table 11: North America Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 12: North America Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 13: North America Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 14: North America Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 15: Europe Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 16: Europe Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 17: Europe Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 18: Europe Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 19: Latin America Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 20: Latin America Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 21: Latin America Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 22: Latin America Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 23: Rest of the World Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 24: Rest of the World Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Indication, 2018–2030
Table 25: Rest of the World Synthetic Cannabinoids Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 26: Mylan N.V. Company Details
Table 27: Mylan N.V. Business Overview
Table 28: Alkem Labs Company Details
Table 29: Alkem Labs Business Overview
Table 30: Noramco Company Details
Table 31: Noramco Business Overview
Table 32: Lygos, Inc. Company Details
Table 33: Lygos, Inc. Business Overview
Table 34: Hyasynth Biologicals, Inc. Company Details
Table 35: Hyasynth Biologicals, Inc. Business Overview
Table 36: Global Synthetic Cannabinoids Market Other Prominent Players, 2019